Greg Preibisch, MD retweeted
Purpose-driven men built this country. Forget the author's odd suggestion that Hitler would’ve liked us (??), i'm appalled by the nostalgia for a golden age when kids wasted their youths drinking and partying.
We stand on the shoulders of young Americans who took their own ambitions seriously. Hamilton’s writing took him out of the Caribbean and transformed American government. Wozniak and Gates built era-defining tech on the passions they pursued as boys.
Let the kids cook, ma’am.
It’s a time-honored American tradition.
San Francisco youth culture died at a peptide party in Fisherman's Wharf sfgate.com/local/article/sf-…
Greg Preibisch, MD retweeted
How aggressive a cancer is and how large is the benefit from chemotherapy are different estimands. Genomic assays were built decades ago for the first and repurposed for the second.
Today, we released 3 preprints on estimating the benefit of escalated treatment directly.
Greg Preibisch, MD retweeted
First in person demo of endgoal groupchats at our Warsaw engineering dinner last night
Greg Preibisch, MD retweeted
Today we're announcing ESMFold2, an open scientific engine to power prediction, design, and discovery across protein biology.
The new model delivers state of the art performance on protein interactions, especially antibodies, a critical modality for therapeutics.
We have designed and validated miniprotein binders and single chain antibodies across five therapeutic targets that are important in cancer and immunology. We are seeing very high success rates, and affinities at levels consistent with therapeutic activity.
We’re also releasing an atlas of 6.8 billion proteins, and 1.1 billion predicted structures.
ESMFold2 is built on a state of the art language model that has been trained on billions of protein sequences.
A world model of protein biology emerges through language modeling.
We’ve used the techniques of mechanistic interpretability developed to understand large language models to understand the concepts ESM uses to represent proteins.
The model’s representation space has a compositional organization of features across scales, levels of complexity, and abstraction, that reflects and mirrors the understanding of protein biology developed through a century of empirical science.
This understanding emerges without prior knowledge, just from language modeling of protein sequences.
Language models are becoming a powerful substrate to understand and program biology.
The design of protein interactions is one of the most fundamental problems in biophysics, and has critical implications for the discovery of new medicines. A simple gradient based search with the model was able to discover high-affinity protein binders.
I'm excited by the potential this has to accelerate basic science and the understanding of proteins. And especially for the new avenues it opens up for therapeutic design and medicine.
Greg Preibisch, MD retweeted
Radar graphs are among the worst ideas in data visualization. The whole point of them is to show the area and you can usually reorder the labels freely in order to create a desired dramatic effect.
Two versions of the same graph:
- left one tells the story that AI is rapidly replacing whole industries
- right one shows the "jaggedness" and reinforces the idea that humans will always have something that AI won't be able to replicate
Greg Preibisch, MD retweeted
Learn more at heypocket.com/now
Greg Preibisch, MD retweeted
sitting downstream of the frontier labs on the value chain is a dangerous place to be imo (even in the life sciences)
specialized verticals would seem to be more insulated, but look at how many connections anthropic is making into downstream specialized knowledge applications in life sciences (quoted list below)
as we've seen in codex, claude code, claude code security, and more - frontier labs are hungry to make your vertical platform a feature on theirs
from a frontier lab perspective, the economics are driving here - as open source LLMs are commoditizing the knowledge api layer, application layer is naturally where you have to go to capture value and justify valuation
this becomes a race of how fast downstream players can build distribution vs how fast life science teams at anthropic, openai, deepmind etc can build features / connections
and since life sciences (and healthcare) is generally a b2b sell (industry R&D researchers don't do IP related work outside of work digital environment), virality is (generally speaking) out of the question
good luck to all in the arena 🙏
Anthropic’s healthcare & life sciences strategy map
1. Investments
• Phylo – AI-native biotech platform
• Heidi – AI ambient scribe
2. Partnerships
• HealthEx – Health data exchange
• Genmab – Antibody therapeutics & R&D
• BioRender – Scientific visualization
• 10x Genomics – Single-cell biology
• Benchling – Biotech R&D cloud infra
• Allen Institute – Biomedical research
• HHMI – Life science research
Greg Preibisch, MD retweeted
Big if open.
Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before.
Head to the comments to read our blog.
Greg Preibisch, MD retweeted
And another new study on the Shingles vaccine with 50% reduction of dementia, Alzheimer's (not a natural experiment)
nature.com/articles/s41467-0…
The Shingles vaccine and reduction of dementia: a new natural experiment from Canada replicated 3 others and adds to this week's link to slowing of biological aging.
erictopol.substack.com/p/spo…
Greg Preibisch, MD retweeted
one of the most well thought-out and researched pieces on the future of physical AI and biological lab automation
as robots take over labs, the fundamentals, however, remain the same: 'clincial validity' rules the day
Heuristics for lab robotics, and where its future may go
(8.4k words, 38 minutes reading time)
owlposting.com/p/heuristics-…
this is the longest article i have ever written. in it, i discuss the three ideologies of lab robotics progress, why they may all converge on the same business model, whether any of it will be actually helpful for the problems that plague drug discovery the most, and more
this article involved discussions with sixteen people over the course of three weeks, and i am very grateful to them for answering the many questions i had about a field that i had long considered alien
finally: this is a complicated field that is really still being birthed, so please let me know if i got anything wrong
Greg Preibisch, MD retweeted
Replying to @ai4s_protenix
@ai4s_protenix We've benchmarked single-sequence mode on OOD de novo designed proteins (confirmed no training data overlap) - Protenix significantly outperforms (2x better results) @ChaiDiscovery across the board. DM if you want to compare notes ;)
Greg Preibisch, MD retweeted
The time of day for cancer immunotherapy is associated with major outcomes. Early is better. Results from a randomized trial of lung cancer, backs up the importance of our circadian rhythm and immune system
nature.com/articles/s41591-0…


































